The global market for Pharma Grade L-Glutamine was valued at US$ 69.6 million in the year 2024 and is projected to reach a revised size of US$ 89 million by 2031, growing at a CAGR of 3.5% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharma Grade L-Glutamine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
L-Glutamine (commonly abbreviated as Gln) is a conditionally essential amino acid that plays a pivotal role in numerous physiological functions, including protein synthesis, immune response, and gut health. Structurally classified among the 20 standard amino acids, L-Glutamine contains an amide group derived from glutamic acid. It is the most abundant free amino acid in the human body, primarily synthesized in skeletal muscles and transported via the bloodstream to various tissues that require it for metabolic processes. L-Glutamine is deemed conditionally essential because, under normal circumstances, the body produces adequate amounts. However, during times of physical stress, such as trauma, surgery, infection, or intense exercise, the demand for L-Glutamine can exceed the body鈥檚 capacity to produce it, necessitating external supplementation.
In commercial form, L-Glutamine is typically produced via microbial fermentation, most commonly using genetically modified strains of bacteria such as Corynebacterium glutamicum or Escherichia coli. The industrial process involves fermenting carbohydrates such as glucose or molasses, followed by purification steps to isolate the amino acid. L-Glutamine is usually available in powdered form but can also be found in capsules, tablets, and functional food products such as protein shakes and fortified bars.
The primary applications of L-Glutamine are found in nutraceuticals, clinical nutrition, sports supplements, functional foods, and animal feed additives. In the field of medicine, L-Glutamine is utilized for its therapeutic benefits in treating conditions such as short bowel syndrome, Crohn鈥檚 disease, and to mitigate the side effects of chemotherapy.
The global Pharma Grade L-Glutamine market has witnessed steady growth over the past decade, driven by increasing health consciousness and heightened demand for immune-boosting products in the wake of the COVID-19 pandemic. The North American and Asia-Pacific regions dominate the market, with Europe following closely behind.
The use of L-Glutamine in medical nutrition therapy is major growth driver. Hospitals and clinical settings use glutamine supplementation in enteral and parenteral nutrition for patients suffering from trauma, burns, or gastrointestinal disorders. Additionally, L-Glutamine has shown promising results in reducing mucositis in cancer patients undergoing chemotherapy or radiation therapy.
As healthcare systems worldwide move from treatment-centric to prevention-centric models, there has been a noticeable rise in demand for functional foods and dietary supplements. L-Glutamine fits into this trend due to its broad application across multiple wellness domains, including digestive health, metabolic health, and immune modulation.
Global Pharma Grade L-Glutamine core manufacturers include Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua and Fufeng, etc. The top three manufacturers account for approximately 75% of the global share. The United States is the world's largest market, accounting for nearly 40% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharma Grade L-Glutamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Grade L-Glutamine.
The Pharma Grade L-Glutamine market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma Grade L-Glutamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Grade L-Glutamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ajinomoto
Kyowa Hakko Kirin
Daesang
Meihua
Fufeng
Segment by Type
Purity 锛�99%
Purity 鈮�99%
Segment by Application
Digestive Health
Metabolic Health
Immune Modulation
Others
Production by Region
North America
Europe
China
Japan
Korea
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma Grade L-Glutamine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharma Grade L-Glutamine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharma Grade L-Glutamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Pharma Grade L-Glutamine 麻豆原创 Overview
1.1 Product Definition
1.2 Pharma Grade L-Glutamine by Type
1.2.1 Global Pharma Grade L-Glutamine 麻豆原创 Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity 锛�99%
1.2.3 Purity 鈮�99%
1.3 Pharma Grade L-Glutamine by Application
1.3.1 Global Pharma Grade L-Glutamine 麻豆原创 Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Digestive Health
1.3.3 Metabolic Health
1.3.4 Immune Modulation
1.3.5 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Pharma Grade L-Glutamine Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharma Grade L-Glutamine Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharma Grade L-Glutamine Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharma Grade L-Glutamine 麻豆原创 Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Pharma Grade L-Glutamine Production 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Pharma Grade L-Glutamine Production Value 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharma Grade L-Glutamine, Industry Ranking, 2023 VS 2024
2.4 Global Pharma Grade L-Glutamine Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharma Grade L-Glutamine Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharma Grade L-Glutamine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharma Grade L-Glutamine, Product Offered and Application
2.8 Global Key Manufacturers of Pharma Grade L-Glutamine, Date of Enter into This Industry
2.9 Pharma Grade L-Glutamine 麻豆原创 Competitive Situation and Trends
2.9.1 Pharma Grade L-Glutamine 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Pharma Grade L-Glutamine Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharma Grade L-Glutamine Production by Region
3.1 Global Pharma Grade L-Glutamine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharma Grade L-Glutamine Production Value by Region (2020-2031)
3.2.1 Global Pharma Grade L-Glutamine Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharma Grade L-Glutamine by Region (2026-2031)
3.3 Global Pharma Grade L-Glutamine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharma Grade L-Glutamine Production Volume by Region (2020-2031)
3.4.1 Global Pharma Grade L-Glutamine Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharma Grade L-Glutamine by Region (2026-2031)
3.5 Global Pharma Grade L-Glutamine 麻豆原创 Price Analysis by Region (2020-2025)
3.6 Global Pharma Grade L-Glutamine Production and Value, Year-over-Year Growth
3.6.1 North America Pharma Grade L-Glutamine Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharma Grade L-Glutamine Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharma Grade L-Glutamine Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharma Grade L-Glutamine Production Value Estimates and Forecasts (2020-2031)
3.6.5 Korea Pharma Grade L-Glutamine Production Value Estimates and Forecasts (2020-2031)
4 Pharma Grade L-Glutamine Consumption by Region
4.1 Global Pharma Grade L-Glutamine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharma Grade L-Glutamine Consumption by Region (2020-2031)
4.2.1 Global Pharma Grade L-Glutamine Consumption by Region (2020-2025)
4.2.2 Global Pharma Grade L-Glutamine Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharma Grade L-Glutamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharma Grade L-Glutamine Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharma Grade L-Glutamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharma Grade L-Glutamine Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharma Grade L-Glutamine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharma Grade L-Glutamine Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharma Grade L-Glutamine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharma Grade L-Glutamine Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharma Grade L-Glutamine Production by Type (2020-2031)
5.1.1 Global Pharma Grade L-Glutamine Production by Type (2020-2025)
5.1.2 Global Pharma Grade L-Glutamine Production by Type (2026-2031)
5.1.3 Global Pharma Grade L-Glutamine Production 麻豆原创 Share by Type (2020-2031)
5.2 Global Pharma Grade L-Glutamine Production Value by Type (2020-2031)
5.2.1 Global Pharma Grade L-Glutamine Production Value by Type (2020-2025)
5.2.2 Global Pharma Grade L-Glutamine Production Value by Type (2026-2031)
5.2.3 Global Pharma Grade L-Glutamine Production Value 麻豆原创 Share by Type (2020-2031)
5.3 Global Pharma Grade L-Glutamine Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pharma Grade L-Glutamine Production by Application (2020-2031)
6.1.1 Global Pharma Grade L-Glutamine Production by Application (2020-2025)
6.1.2 Global Pharma Grade L-Glutamine Production by Application (2026-2031)
6.1.3 Global Pharma Grade L-Glutamine Production 麻豆原创 Share by Application (2020-2031)
6.2 Global Pharma Grade L-Glutamine Production Value by Application (2020-2031)
6.2.1 Global Pharma Grade L-Glutamine Production Value by Application (2020-2025)
6.2.2 Global Pharma Grade L-Glutamine Production Value by Application (2026-2031)
6.2.3 Global Pharma Grade L-Glutamine Production Value 麻豆原创 Share by Application (2020-2031)
6.3 Global Pharma Grade L-Glutamine Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Ajinomoto
7.1.1 Ajinomoto Pharma Grade L-Glutamine Company Information
7.1.2 Ajinomoto Pharma Grade L-Glutamine Product Portfolio
7.1.3 Ajinomoto Pharma Grade L-Glutamine Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Ajinomoto Main Business and 麻豆原创s Served
7.1.5 Ajinomoto Recent Developments/Updates
7.2 Kyowa Hakko Kirin
7.2.1 Kyowa Hakko Kirin Pharma Grade L-Glutamine Company Information
7.2.2 Kyowa Hakko Kirin Pharma Grade L-Glutamine Product Portfolio
7.2.3 Kyowa Hakko Kirin Pharma Grade L-Glutamine Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Kyowa Hakko Kirin Main Business and 麻豆原创s Served
7.2.5 Kyowa Hakko Kirin Recent Developments/Updates
7.3 Daesang
7.3.1 Daesang Pharma Grade L-Glutamine Company Information
7.3.2 Daesang Pharma Grade L-Glutamine Product Portfolio
7.3.3 Daesang Pharma Grade L-Glutamine Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Daesang Main Business and 麻豆原创s Served
7.3.5 Daesang Recent Developments/Updates
7.4 Meihua
7.4.1 Meihua Pharma Grade L-Glutamine Company Information
7.4.2 Meihua Pharma Grade L-Glutamine Product Portfolio
7.4.3 Meihua Pharma Grade L-Glutamine Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Meihua Main Business and 麻豆原创s Served
7.4.5 Meihua Recent Developments/Updates
7.5 Fufeng
7.5.1 Fufeng Pharma Grade L-Glutamine Company Information
7.5.2 Fufeng Pharma Grade L-Glutamine Product Portfolio
7.5.3 Fufeng Pharma Grade L-Glutamine Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Fufeng Main Business and 麻豆原创s Served
7.5.5 Fufeng Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharma Grade L-Glutamine Industry Chain Analysis
8.2 Pharma Grade L-Glutamine Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharma Grade L-Glutamine Production Mode & Process Analysis
8.4 Pharma Grade L-Glutamine Sales and 麻豆原创ing
8.4.1 Pharma Grade L-Glutamine Sales Channels
8.4.2 Pharma Grade L-Glutamine Distributors
8.5 Pharma Grade L-Glutamine Customer Analysis
9 Pharma Grade L-Glutamine 麻豆原创 Dynamics
9.1 Pharma Grade L-Glutamine Industry Trends
9.2 Pharma Grade L-Glutamine 麻豆原创 Drivers
9.3 Pharma Grade L-Glutamine 麻豆原创 Challenges
9.4 Pharma Grade L-Glutamine 麻豆原创 Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Ajinomoto
Kyowa Hakko Kirin
Daesang
Meihua
Fufeng
听
听
*If Applicable.
